Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue
May 1, 2026 6:37 AM EDTModerna (NASDAQ: MRNA) reported Q1 EPS of ($3.40), $1.38 worse than the analyst estimate of ($2.02). Revenue for the quarter came in at $389 million versus the consensus estimate of $251.76 million.
For earnings history and earnings-related data on Moderna (MRNA) click here.
... More